There are good reasons to balance Cloud infrastructure between multiple vendors.
In Part One of this series, we discussed some of the applications and workflows best-suited for public Cloud deployment. But public Cloud deployments are not the only option for life science researchers and biopharmaceutical IT teams. Hybrid Cloud and multi-Cloud environments can offer the same benefits in a way that’s better aligned to stakeholder interests.
What is a Multi-Cloud Strategy?
Multi-Cloud refers to an architectural approach that uses multiple Cloud computing services in parallel. Organizations that adopt a multi-Cloud strategy are able to distribute computing resources across their deployments and minimize over-reliance on a single vendor.
Multi-Cloud deployments allow Life Science researchers and Bio-IT teams to choose between multiple public Cloud vendors when distributing computing resources. Some Cloud platforms are better suited for certain tasks than others, and being able to choose between multiple competing vendors puts the organization at an overall advantage.
Why Bio-IT Teams Might Want to Adopt a Multi-Cloud Strategy
Working with a single Cloud computing provider for too long can make it difficult to move workloads and datasets from one provider to another. Especially as needs and requirements change which, as we know, is quite often within Life Sciences organizations. Highly centralized IT infrastructure tends to accumulate data gravity – the tendency for data analytics and other applications to converge on large data repositories, making it difficult to scale data capabilities outwards.
This may go unnoticed until business or research goals demand migrating data from one platform to another. At that point, the combination of data gravity and vendor lock-in can suddenly impose unexpected technical, financial, and legal costs.
Cloud vendors do not explicitly prevent users from migrating data and workflow applications. However, they have a powerful economic incentive to make the act of migration as difficult as possible. Letting users flock to their competitors is not strictly in their interest.
Not all Cloud vendors do this, but any Cloud vendor can decide to. Since Cloud computing agreements can change over time, users who deploy public Cloud technology with a clear strategy for avoiding complex interdependencies will generally fare better than users who simply go “all in” with a single vendor.
Multi-Cloud deployments offer Life Science research organizations a structural way to eliminate over-reliance on a single Cloud vendor. Working with multiple vendors from the start demands researchers and IT teams plan for data and application portability from the beginning.
Multi-Cloud deployments also allow IT teams to better optimize diverse workflows with scalable computing resources. When researchers demand new workloads, their IT partners can choose an optimal platform for each one of them on a case-by-case basis.
This allows researchers and IT teams to coordinate resources more efficiently. One research application’s use of sensitive data may make it better suited for a particular Cloud provider, while another workflow demands high-performance computing resources only available from a different provider. Integrating multiple Cloud providers under a single framework can enable considerable efficiencies through each stage of the research process.
What About Hybrid Cloud?
Hybrid Clouds are IT architectures that rely on a combination of private Cloud resources alongside public Cloud systems. Private Cloud resources are simply Cloud-based architectures used exclusively by one organization.
For example, imagine your life science firm hosts some research applications on its own internal network but also uses Microsoft Azure and Amazon AWS. This is a textbook example of a multi-Cloud architecture that is also hybrid.
Hybrid Cloud environments may offer benefits to Life Science researchers that need security and compliance protection beyond what public Cloud vendors can easily offer. Private Cloud frameworks are ideal for processing and storing sensitive data.
Hybrid Cloud deployments may also present opportunities to reduce overall operating expenses over time. If researchers are sure they will consistently use certain Cloud computing resources frequently for years, hosting those applications on a private Cloud deployment may end up being more cost-efficient over that period.
It’s common for Bio-IT teams to build private on-premises Cloud systems for small, frequently used applications and then use easily scalable public Cloud resources to handle less frequent high-performance computing jobs. This hybrid approach allows life science research organizations to get the best of both worlds.
Optimize your Cloud Strategy for Achieving Research Goals
Life Science research organizations generate value by driving innovation in a dynamic and demanding field. Researchers who can perform computing tasks on the right platform and infrastructure for their needs are ideally equipped to make valuable discoveries. Public Cloud, multi-Cloud, and hybrid Cloud deployments are all viable options for optimizing Life Science research with proven technology.
RCH Solutions is a global provider of computational science expertise, helping Life Sciences and Healthcare firms of all sizes clear the path to discovery for nearly 30 years. If you’re interesting in learning how RCH can support your goals, get in touch with us here.